Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: a possible cause for the limited effectiveness of monotherapy with small-molecule inhibitors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples